top of page
Search
Can Your Pharma Brand Value Proposition Win in a World Without Rebates?
Brand, payer marketing, market access, and managed markets teams: Are you prepared for a call from the boardroom to review your brand’s...

Aventria Health Group
May 20, 20193 min read
5 Pharma Brand Growth Myths: Impediments at Large Provider Customers (IDNs, LGPs, etc)
It’s not often that we hear pharma clients communicate high satisfaction with their KAM approach and sales performance, and that’s to be...

Aventria Health Group
May 14, 20193 min read
8 Strategies for Pharma Market Access Teams to Get Ahead of HHS Transparency Proposals
If you are on the brand, market access, or managed markets team at your pharmaceutical company, likely you are already well aware of the...

Aventria Health Group
Apr 28, 20195 min read
Can Pharma and Health Systems Collaborate?
The number of pharmaceutical sales representatives has declined nationwide from about 120,000 to around 70,000. Meanwhile...

Aventria Health Group
Feb 1, 20196 min read
The Opioid Crisis in the United States: What It Means for Employers
Since the 1990s, the use of opioids to treat moderate to severe pain has increased dramatically.

Aventria Health Group
Nov 21, 20184 min read
bottom of page
